HFF Closes $337.5 Million Sale of and Financing of GSK Global Vaccine Centre in Rockville, Maryland
Chi-Med appoints Industry Veteran Paul Carter to Board of Directors
UPDATE: Drug makers, auto stocks yank European stocks lower for first time in 3 days
LONDON MARKETS: FTSE 100 Logs 10th Day Of All-time Highs
UPDATE: FTSE 100 logs 10th day of all-time highs
EUROPE MARKETS: Drug Makers Struggle, Pulling European Markets Lower
UPDATE: Drug makers struggle, pulling European markets lower
Launch of New Drugs to Impact Positively on the Infectious and Rare Diseases Market: Technavio
GlaxoSmithKline GSK reported solid second-quarter results on Wednesday that were largely in line with our expectations, and we don't anticipate any changes to our fair value estimate. Sales increased 10% from the prior year driven by strong sales of asthma medicine Advair, diabetes medicine ...
This ETF holds a swath of large- and mid-cap U.S. healthcare companies.